Compare Roivant Sciences Ltd. Common Shares (ROIV) vs ProShares Ultra Gold ETF (UGL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Roivant Sciences Ltd. Common Shares vs ProShares Ultra Gold ETF — how do they compare? Roivant Sciences Ltd. Common Shares trades at $34.85 (market cap $24.72B), while ProShares Ultra Gold ETF trades at $46.34 (market cap $716.59M). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 34.5× ProShares Ultra Gold ETF's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, ProShares Ultra Gold ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and ProShares Ultra Gold ETF for 23 Days on average.
| ROIV | UGL | |
|---|---|---|
Market Cap | $24.72B | $716.59M |
Volume | 6,279,442 | 2,592,878 |
Sector | Health | Leveraged / Inverse |
52-Week High | $41.81 | $85.62 |
52-Week Low | $16.04 | $42.79 |
Typical Hold Time | 0 Days | 23 Days |
Enterprise Value | $20.99B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
UGL trades at $46.24, up 4.07% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The stock faces resistance near $46 and support at $45. Financial ratios are unavailable, limiting fundamental assessment. Recent gold-related news highlights volatility from Treasury yields and Fed policy, influencing sentiment.
Outlook remains cautious due to bearish technicals and macroeconomic pressures. Risks include interest rate sensitivity and lack of financial transparency. Investors should await earnings reports for fundamental clarity amid current market uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →About ProShares Ultra Gold ETF
UGL is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Gold Subindex. It is a tactical tool designed for sophisticated investors to magnify short-term bullish views on gold prices through the use of futures and swap contracts, rather than holding physical bullion.
Read more on UGL →
